BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Business

  Array BioPharma, Inc. to Get Up to $387 Million in Upfront, Milestone Payments Under Celgene Corporation Pact

  July 30, 2013

   · 

  4 min read
• Business

  Pfizer Inc.'s Success Again Sharply Contrasts With Merck & Co., Inc.'s Woes

  July 30, 2013

   · 

  1 min read
• Drug Development

  FDA Lifts Clinical Hold on Cangene Corporation’s Hemophilia Compound IB1001

  July 30, 2013

   · 

  6 min read
• Deals

  Kinetic Concepts, Inc. Buys Systagenix for $485 Million

  July 30, 2013

   · 

  5 min read
• Genetown

  GI Dynamics Raises $34.76 Million to Fund U.S. Pivotal Clinical Trial, Execute Commercial Strategy Abroad

  July 30, 2013

   · 

  1 min read
• Deals

  Foundation Medicine Lays Groundwork for $86 Million IPO

  July 30, 2013

   · 

  1 min read
• Hospital Death Forces Recall of GE Healthcare’s Nuclear Medicine Machines

  July 30, 2013

   · 

  1 min read
• FDA

  Stereotaxis, Inc. Receives FDA Clearance of Vdrive™ With V-Sono™ System

  July 30, 2013

   · 

  4 min read
• Policy

  FDA Reviewers: Sanofi (France)'s Allergy Drug Can Go OTC

  July 30, 2013

   · 

  1 min read
• Patient Taking Novartis AG MS Pill Developed Rare Disease

  July 30, 2013

   · 

  1 min read